Track market-moving stories before they get noisy

Toyota Motor Corporation (TM - Free Report) closed at $178.19 in the latest trading session, marking a -1.13% move from the prior day. The stock fell short of the S&P 500, which registered a loss of 0.57% for the day. On the other hand, the Dow registered a gain of 0.64%, and the technology-centric Nasdaq decreased by 1.15%.

Coming into today, shares of the company had lost 3.82% in the past month. In that same time, the Auto-Tires-Trucks sector lost 0.94%, while the S&P 500 gained 2.14%.

Investors will be eagerly watching for the performance of Toyota Motor Corporation in its upcoming earnings disclosure.

TM's full-year Zacks Consensus Estimates are calling for earnings of $21.11 per share and revenue of $325.63 billion. These results would represent year-over-year changes of +7.65% and -3.2%, respectively.

Investors might also notice recent changes to analyst estimates for Toyota Motor Corporation. These revisions help to show the ever-changing nature of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.

Based on our research, we believe these estimate revisions are directly related to near-term stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 4.49% higher. At present, Toyota Motor Corporation boasts a Zacks Rank of #4 (Sell).

Valuation is also important, so investors should note that Toyota Motor Corporation has a Forward P/E ratio of 8.54 right now. This valuation marks a discount compared to its industry average Forward P/E of 10.18.

The Automotive - Foreign industry is part of the Auto-Tires-Trucks sector. This industry currently has a Zacks Industry Rank of 176, which puts it in the bottom 28% of all 250+ industries.

The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

To follow TM in the coming trading sessions, be sure to utilize Zacks.com.

Paramount Skydance refused to air an ad submitted by a press freedom group that heavily criticized the network’s leadership and merger with Warner Bros Discovery, with an advertising associate deeming it a “conflict of interest”.

The Freedom of the Press Foundation had hoped to air the 30-second ad during Sunday’s Ultimate Fighting Championship broadcast at the White House, which aired on the streaming service Paramount+ – though a client partner for Paramount+ told the organization’s ad-buyer that such placement was not guaranteed.

“Instead of defending press freedom, CBS’ billionaire owners cut deals and caved to Trump,” the unaired ad states, before touching on the recent uproar at the Sunday show 60 Minutes. “One fired reporter said, ‘CBS demanded falsehoods and bias to appease Trump.’ Now Trump wants the Ellisons to buy CNN, too … Let’s stop Trump’s censorship and block this merger.”

According to an email exchange between Paramount’s ad salesperson and the Freedom of the Press Foundation’s ad buyer, viewed by the Guardian, the discussion about running an ad was going smoothly until the ad was actually submitted. (The organization was told that ads running during the UFC broadcast would cost approximately $300,000.)

Then, on Friday afternoon, two days before the fight, the Paramount salesman sent word that the ad could not run. “Unfortunately, the creative you submitted was a conflict of interest so it was not approved,” the sales representative said. “But we can help you check any other creatives you want to try. Always happy to hop on a call to discuss more.”

Seth Stern, chief of advocacy for Freedom of the Press Foundation, criticized Paramount for refusing to air the ad – although television networks regularly reject advocacy messages for a variety of reasons.

“Ellison has already shown his cards on editorial independence, but, in case there was any doubt, his company has now declined to air a straightforward message about what his proposed takeover of CNN, HBO, and other outlets would mean for press freedom. Instead, it censored it,” Stern said in a statement. “Ellison won’t air criticism of himself, his company, or his buddy Trump. These antics are bad for press freedom, bad for the public, and bad for Paramount – just look at CBS’ recent struggles under Ellison’s watch.”

Stern’s organization instead plans to air the ad on its website dedicated to opposing the merger, which received approval from Donald Trump’s Department of Justice on Friday but still faces regulatory hurdles outside the United States.

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.

Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.

Zacks Premium also includes the Zacks Style Scores.

What are the Zacks Style Scores? Developed alongside the Zacks Rank, the Zacks Style Scores are a group of complementary indicators that help investors pick stocks with the best chances of beating the market over the next 30 days.

Each stock is given an alphabetic rating of A, B, C, D or F based on their value, growth, and momentum qualities. With this system, an A is better than a B, a B is better than a C, and so on, meaning the better the score, the better chance the stock will outperform.

The Style Scores are broken down into four categories:

Value ScoreValue investors love finding good stocks at good prices, especially before the broader market catches on to a stock's true value. Utilizing ratios like P/E, PEG, Price/Sales, Price/Cash Flow, and many other multiples, the Value Style Score identifies the most attractive and most discounted stocks.

Growth ScoreWhile good value is important, growth investors are more focused on a company's financial strength and health, and its future outlook. The Growth Style Score takes projected and historic earnings, sales, and cash flow into account to uncover stocks that will see long-term, sustainable growth.

Momentum ScoreMomentum investors, who live by the saying "the trend is your friend," are most interested in taking advantage of upward or downward trends in a stock's price or earnings outlook. Utilizing one-week price change and the monthly percentage change in earnings estimates, among other factors, the Momentum Style Score can help determine favorable times to buy high-momentum stocks.

VGM ScoreIf you like to use all three kinds of investing, then the VGM Score is for you. It's a combination of all Style Scores, and is an important indicator to use with the Zacks Rank. The VGM Score rates each stock on their shared weighted styles, narrowing down the companies with the most attractive value, best growth forecast, and most promising momentum.

How Style Scores Work with the Zacks Rank The Zacks Rank, which is a proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, to make building a winning portfolio easier.

Investors can count on the Zacks Rank's success, with #1 (Strong Buy) stocks producing an unmatched +24% average annual return since 1988, more than double the S&P 500's performance. But the model rates a large number of stocks, and there are over 200 companies with a Strong Buy rank, plus another 600 with a #2 (Buy) rank, on any given day.

With more than 800 top-rated stocks to choose from, it can certainly feel overwhelming to pick the ones that are right for you and your investing journey.

That's where the Style Scores come in.

To maximize your returns, you want to buy stocks with the highest probability of success. This means picking stocks with a Zacks Rank #1 or #2 that also have Style Scores of A or B. If you find yourself looking at stocks with a #3 (Hold) rank, make sure they have Scores of A or B as well to ensure as much upside potential as possible.

The direction of a stock's earnings estimate revisions should always be a key factor when choosing which stocks to buy, since the Scores were created to work together with the Zacks Rank.

Here's an example: a stock with a #4 (Sell) or #5 (Strong Sell) rating, even one with Style Scores of A and B, still has a downward-trending earnings outlook, and a bigger chance its share price will decrease too.

Thus, the more stocks you own with a #1 or #2 Rank and Scores of A or B, the better.

Stock to Watch: NetApp (NTAP - Free Report) NetApp provides enterprise storage as well as data management software and hardware products and services. The San Jose, CA-based company assists enterprises in managing multiple clouds environments, adopting next-generation technologies like artificial intelligence (AI), Kubernetes, and contemporary databases, and navigating the complexity brought about by the quick development of data and cloud usage.

NTAP is a #3 (Hold) on the Zacks Rank, with a VGM Score of A.

Additionally, the company could be a top pick for growth investors. NTAP has a Growth Style Score of A, forecasting year-over-year earnings growth of 9.2% for the current fiscal year.

For fiscal 2027, seven analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.28 to $8.88 per share. NTAP boasts an average earnings surprise of +4.7%.

With a solid Zacks Rank and top-tier Growth and VGM Style Scores, NTAP should be on investors' short list.

Carvana (CVNA - Free Report) closed the last trading session at $68.9, gaining 4.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $94.4 indicates a 37% upside potential.

The mean estimate comprises 20 short-term price targets with a standard deviation of $10.73. While the lowest estimate of $67.00 indicates a 2.8% decline from the current price level, the most optimistic analyst expects the stock to surge 74.2% to reach $120.00. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.

While the consensus price target is a much-coveted metric for investors, solely banking on this metric to make an investment decision may not be wise at all. That's because the ability and unbiasedness of analysts in setting price targets have long been questionable.

But, for CVNA, an impressive average price target is not the only indicator of a potential upside. Strong agreement among analysts about the company's ability to report better earnings than they predicted earlier strengthens this view. While a positive trend in earnings estimate revisions doesn't gauge how much a stock could gain, it has proven to be powerful in predicting an upside.

Price, Consensus and EPS Surprise

Here's What You Should Know About Analysts' Price TargetsAccording to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that price targets set by several analysts, irrespective of the extent of agreement, rarely indicate where the price of a stock could actually be heading.

While Wall Street analysts have deep knowledge of a company's fundamentals and the sensitivity of its business to economic and industry issues, many of them tend to set overly optimistic price targets. Are you wondering why?

They usually do that to drum up interest in shares of companies that their firms either have existing business relationships with or are looking to be associated with. In other words, business incentives of firms covering a stock often result in inflated price targets set by analysts.

However, a tight clustering of price targets, which is represented by a low standard deviation, indicates that analysts have a high degree of agreement about the direction and magnitude of a stock's price movement. While that doesn't necessarily mean the stock will hit the average price target, it could be a good starting point for further research aimed at identifying the potential fundamental driving forces.

That said, while investors should not entirely ignore price targets, making an investment decision solely based on them could lead to disappointing ROI. So, price targets should always be treated with a high degree of skepticism.

Here's Why There Could be Plenty of Upside Left in CVNAAnalysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason to expect an upside in the stock. That's because empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

The Zacks Consensus Estimate for the current year has increased 0.6% over the past month, as one estimate has gone higher compared to no negative revision.

Moreover, CVNA currently has a Zacks Rank #1 (Strong Buy), which means it is in the top 5% of more than 4,000 stocks that we rank based on four factors related to earnings estimates. Given an impressive externally-audited track record, this is a more conclusive indication of the stock's potential upside in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Therefore, while the consensus price target may not be a reliable indicator of how much CVNA could gain, the direction of price movement it implies does appear to be a good guide.

Carvana (CVNA - Free Report) closed the most recent trading day at $70.04, moving +1.65% from the previous trading session. This change outpaced the S&P 500's 0.57% loss on the day. On the other hand, the Dow registered a gain of 0.64%, and the technology-centric Nasdaq decreased by 1.15%.

The company's stock has climbed by 4.36% in the past month, exceeding the Retail-Wholesale sector's loss of 3.04% and the S&P 500's gain of 2.14%.

The upcoming earnings release of Carvana will be of great interest to investors. In that report, analysts expect Carvana to post earnings of $0.42 per share. This would mark year-over-year growth of 61.54%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $6.9 billion, up 42.6% from the year-ago period.

Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $1.58 per share and revenue of $27.58 billion. These totals would mark changes of -6.51% and +35.72%, respectively, from last year.

It's also important for investors to be aware of any recent modifications to analyst estimates for Carvana. These revisions typically reflect the latest short-term business trends, which can change frequently. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability.

Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, there's been a 0.64% rise in the Zacks Consensus EPS estimate. At present, Carvana boasts a Zacks Rank of #1 (Strong Buy).

In the context of valuation, Carvana is at present trading with a Forward P/E ratio of 43.61. This represents a premium compared to its industry average Forward P/E of 16.73.

Also, we should mention that CVNA has a PEG ratio of 11.63. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The average PEG ratio for the Internet - Commerce industry stood at 1.01 at the close of the market yesterday.

The Internet - Commerce industry is part of the Retail-Wholesale sector. With its current Zacks Industry Rank of 109, this industry ranks in the top 45% of all industries, numbering over 250.

The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.

The energy company will spend more on oil and gas projects in a bid to grow production and increase shareholder returns.

The automaker-owned platform will integrate Rivian EV batteries, some of the largest in the market June 16, 2026 08:00 ET  | Source: ChargeScape

IRVINE, Calif. and AUSTIN, Texas, June 16, 2026 (GLOBE NEWSWIRE) -- American automotive and technology company Rivian (NASDAQ: RIVN) and ChargeScape, the vehicle-grid integration platform owned by a consortium of automakers, today announced a partnership to enroll Rivian’s high-capacity EV batteries into utility managed-charging programs.

Through this partnership, Rivian EV drivers will be able to opt into ChargeScape’s growing network of utility programs across North America, unlocking new ways to save on charging costs while supporting the grid. Rivian EVs already serve as a resource for the grid, but now they can seamlessly connect through partners like ChargeScape’s broad network of power utilities, to serve as even more powerful flexible grid assets to help balance peak grid demands.

Unlike other aggregators, ChargeScape operates as a shared, industry-owned automotive infrastructure platform, backed by BMW, Ford, Honda, and Nissan and utilized by Tesla, Stellantis and others. Rivian’s partnership with ChargeScape represents a shared belief in the importance of a simple, customer-friendly approach to grid-integrated electric vehicles that prioritizes scalability, interoperability, and direct OEM involvement.

Once integrated with ChargeScape’s platform, Rivian EVs can serve as even more powerful, and more flexible energy resources for a utility’s managed charging program. Rivian vehicles can support grid resiliency by offering up meaningful flexible capacity, all while enabling customers to maintain a seamless, in-app charging and enrollment experience.

“This is a significant step forward in aligning automakers around a common platform and charging standard,” said Joseph Vellone, CEO of ChargeScape. “Rivian’s partnership with ChargeScape will bring some of the largest batteries on the road onto an industry-owned, shared infrastructure. At a time of persistent inflation and high gas prices, we’re unlocking meaningful financial savings for EV drivers across America.”

      "Through this collaboration with ChargeScape and other partners, Rivian’s software-enabled vehicles are a perfect, nimble partner to help balance the energy grid and enable drivers to get more value out of their vehicle,” said Andrew Peterman, Director of Advanced Energy Solutions at Rivian. “These solutions demonstrate how electric vehicles can help reduce electricity costs and support a more resilient energy grid for everyone, whether you own an EV or not."

As utilities across the United States face growing strain from data center demand, they are increasingly tapping into the flexible capacity offered by the almost 7 million EVs on American roads. By integrating Rivian’s award-winning vehicles into a platform that’s built by automakers and trusted by utilities, ChargeScape is further expanding its role at the center of a more dynamic and responsive energy ecosystem.

About ChargeScape:

ChargeScape is the automaker-backed vehicle-grid integration platform that officially connects OEMs with power utilities. The platform manages EV charging programs, reaching millions of households nationwide, offering both V1G managed charging and V2X capabilities across dozens of utility partners.

About Rivian:

Rivian (NASDAQ: RIVN) is an American automotive technology company that develops and manufactures category-defining electric vehicles as well as vertically integrated technologies and services. Through innovation across its electrical architecture, end-to-end software, autonomous driving platform, artificial intelligence and propulsion, the company creates vehicles that excel at work and play while accelerating the global transition to zero-emission transportation and energy. Rivian vehicles are manufactured in the United States and are sold directly to consumer and commercial customers. Whether taking families on new adventures or electrifying fleets at scale, Rivian vehicles all share a common goal – preserving the natural world for generations to come. Learn more about the company, products, and careers at www.rivian.com.

Media Contact:

FischTank PR
[email protected]

Rivian
[email protected]

Photos accompanying this announcement are available at 

https://www.globenewswire.com/NewsRoom/AttachmentNg/187a66bc-77e4-4164-aa06-2894e5804dad

https://www.globenewswire.com/NewsRoom/AttachmentNg/93e36fda-4199-4803-a682-9e57c2be1179

Rivian R2 at-home charging A Rivian R2 is plugged in to charge. Rivian R2, charging at home A Rivian R2 charges at home, managed by ChargeScape's vehicle-grid integration platform.

ChargeScape website

Rivian said Tuesday it was laying off hundreds of workers, or less than 2% of its workforce, as the electric vehicle maker aims to narrow losses.

The layoffs affect some teams in the service and customer segments, according to a spokesperson. The company had 15,232 employees across North America and Europe at the end of last year.

"We recently restructured a handful of teams within Rivian as we work to profitably scale our business," the company said in a statement.

The layoffs come a week after the automaker officially launched deliveries of its key new vehicle, the R2 SUV. The R2 is meant to transform Rivian from a niche EV manufacturer that sells luxury vehicles into a more mainstream brand like U.S. EV leader Tesla. The layoffs were first reported by The Wall Street Journal.

Rivian has said it hopes to achieve profitability with the R2. It has never turned an annual profit.

The EV maker lost $3.6 billion last year, while only delivering 42,247 vehicles, according to company filings. Its automotive segment lost about $6,000 per vehicle it delivered during the first quarter of this year.

Rivian and other EV manufacturers are increasingly facing a more challenging market than they did in recent years amid changing regulations under the Trump administration, including the elimination of a $7,500 federal incentive for purchasing an EV.

Rivian laid off more than 600 workers in October, or roughly 4.5% of its workforce. Those cuts largely involved restructurings of its marketing, vehicle operations, and sales/delivery and mobile operations teams.

By You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.

Rivian confirmed to Business Insider that it's cutting some sales and marketing staff as it aims for profitability. Scott Olson/Getty Images Rivian is doing a small round of layoffs hot on the heels of its latest vehicle launch.

The EV maker is cutting less than 2% of its workforce amid a make-or-break year.

"We recently restructured a handful of teams within Rivian as we work to profitably scale our business," a company spokesperson told Business Insider in a statement.

The cuts affected some teams in Rivian's service and customer organization, which includes go-to-market functions such as sales and marketing, the spokesperson said. The company said the changes are intended to help Rivian scale more efficiently as it works toward building a healthy and profitable business.

A person familiar with the layoffs told Business Insider that some affected employees were notified directly by managers.

The layoffs come as Rivian launches its third — and most important — consumer product, the midsize R2 SUV. The company's two other passenger vehicles, the R1T pickup and the R1S three-row SUV, have helped establish Rivian as a premium EV brand but have not made the company profitable on a net income basis.

Rivian started deliveries of its R2 EV earlier in June.  Jay Janner/The Austin American-Statesman via Getty Images Rivian began delivering the first R2s to customers on June 9. The midsize SUV slots into America's most popular vehicle segment and competes with Tesla's Model Y, one of the world's best-selling cars.

The spokesperson said Rivian remains confident in the R2 and the company's ability to deliver and ramp the five-seater to customers.

Affected workers are eligible for rehire and are encouraged to apply for other open roles at Rivian, the spokesperson said. The company is providing severance packages, benefits, and career-transition services.

Read next

Ben Shimkus You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.

Ben Shimkus is a reporter for the Business News desk. He writes about cars, transportation, retail, and jobs. Ben's reporting has appeared in Rolling Stone, The Verge, Automotive News, USA Today, AutoBody News, LGBTQ Nation, TopSpeed, and Out Magazine. He's also held staff writing positions at The U.S. Sun and the Daily Mail. He graduated from NYU with a Master's in journalism in 2024. Email Ben at [email protected] or message him privately on Signal at bshimkus.41. 

Layoffs

WALTHAM, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano”, or the “Company”) and Infinite Epigenetics™ (“Infinite Epigenetics,” “Infinite”) today issued the following shareholder update to provide additional detail on the proposed business combination announced on June 15, 2026. The Company has carefully reviewed Murchinson’s recent letter regarding the proposed transaction with Infinite. While we welcome shareholder engagement and are committed to transparency, the final details of the transaction are still being negotiated. However, we would like to address specific questions posed by Murchinson, contextualize the Infinite story and commercial success achieved, and provide further perspective on the substantial value creation of the proposed transaction. We will then provide complete details and a description of the proposed transaction for discussion with shareholders once finalized. We recognize that this is a complex transaction and appreciate the feedback that we have received so far; we look forward to continued discussions with shareholders about this transaction with the benefit of full and finalized information, and the exciting path forward for Nano.

A Real Business with Proven Science in a Well-Established Market

Murchinson's letter ignores the central fact that Nano's Board of Directors (the “Board”) evaluated: Infinite Epigenetics is not a concept company and not an AI wrapper around generic healthcare data. It is built on operating businesses, a CLIA-certified methylation laboratory, established science, and defensible proprietary assets, which is precisely why the Board believes this combination presents a compelling long-term value creation opportunity for shareholders.  

The science is established, not speculative. Epigenetics is one of the most extensively validated areas of modern molecular biology, supported by a deep and growing body of peer-reviewed research, including over 50 publications authored by experts within Infinite’s team. A single sample processed in Infinite's CLIA-certified laboratory can read more than one million epigenetic signals, and its proprietary database comprises more than 120,000 biological samples, among the largest private DNA methylation datasets in the world. This is not a concept awaiting proof. It is an operating diagnostic platform with existing commercial revenue, a network of more than 7,500 healthcare providers, and issued intellectual property.

The category is proven by public-market leaders. The model of building a category-defining molecular diagnostics company is well established, and three multi-billion-dollar public companies have each validated a different piece of what Infinite is building. GRAIL (~$2.5B Market Cap) demonstrated that methylation-based diagnostics can detect disease. Exact Sciences (valued at ~$21B in announced acquisition by Abbott), with Cologuard, demonstrated that a molecular diagnostic test can achieve broad clinical adoption and payor reimbursement and scale into a household name. Tempus AI (~$9B Market Cap) demonstrated that proprietary biological data paired with AI commands a premium public-market valuation. Notably, Brad Keywell, Original Investor & Board Member of Tempus AI, is the Chairman of Infinite’s board, a reflection of experienced confidence in Infinite's approach.

Infinite is pursuing all three of these proven strategies: methylation-based detection, a scaled clinical testing business, and a proprietary data-and-AI platform, simultaneously, on a single platform and across multiple disease areas. The opportunity these companies illustrate is precisely the one Murchinson overlooks: enormous value is created as a data-driven diagnostics platform scales, and that value accrues to those who participate early rather than after it has already been recognized in the public markets. Moreover, by utilizing AI, Infinite can scale its business with a fraction of the capital required by its predecessors.

Clear Strategic Rationale and Capital Plan

Of the approximately 20 opportunities that the Nano leadership thoroughly evaluated, Infinite was selected as the single greatest candidate to drive value for Nano’s shareholders. While Infinite represents a transition of Nano’s operations from 3D printing to AI-powered preventive health and diagnostics, the Board believes the next wave of healthcare AI will be built on proprietary biological data, not generic medical text, and Infinite's focus on DNA methylation is a distinct and complementary frontier. The chronic disease diagnostics market exceeds $90 billion, significantly larger than the 3D printing industry. The Board's focus is on capturing the biggest addressable market for shareholders, which this opportunity delivers.

Infinite is developing the next step: a multi-omics foundation model trained in biology rather than language. Its AI strategy begins with a live, provider-facing assistant that helps clinicians interpret methylation reports today, but the chatbot is merely the interface. The real value sits underneath it, in the biological foundation model and the IP that powers it: a proprietary dataset, proprietary algorithms, multiple patents, and existing commercial scale, designed to learn from methylation data and clinical context that cannot be scraped from the internet. This is the defined purpose of Nano's capital: to accelerate the data, validation, compute, and clinical infrastructure that turn a real diagnostics business into a compounding biological AI platform, an asset that cannot be easily replicated and grows more valuable over time.

This transaction is not a search for a use of capital, it is a plan to deploy capital against a specific, defensible asset. The capital would fund two complementary engines of value. First, it would accelerate commercialization of Infinite's existing diagnostic and consumer operations, expanding the provider network, test volume, and multiple revenue lines of an already-operating business. Second, it would fund the continued expansion of Infinite's proprietary methylation dataset and the development of its biological AI platform: the data engine and the models that translate epigenetic signals into earlier detection of major chronic diseases.

The epigenome records what is happening in your body right now, governing which genes are turned on or off in response to age, environment, and disease. The AI models that are currently prominent in computational biology are trained on static gene sequencing and predict average population behavior, not the functional state of a real person measured over time. Only epigenetic data can do this. Infinite uniquely owns one of the world’s largest epigenetic datasets with more than 120,000 samples, making it one of the only platforms capable of executing this vision. The result is a compounding dynamic. Commercial growth generates more proprietary data, that data strengthens the AI platform, and the platform deepens a competitive advantage that cannot be easily replicated and grows more valuable over time. Unlike genetic testing, which returns the same fixed result every time, epigenetic testing is dynamic and longitudinal: a patient's biology changes over time, so they can be retested again and again. That makes it a recurring model rather than a one-time transaction, and every repeat test feeds the model, making it smarter.

Finally, this transaction differs meaningfully from a SPAC. This is not a situation where the amount of cash at closing is unclear, the capitalization table is over-burdened by warrants and the external sponsor receives a significant promote. Rather, this transaction reflects a value-accretive combination with a defined operating business. Unlike a SPAC, the Company remains an operating platform with existing assets, and capital and strategic direction. Further, in the contemplated transaction, the premium to Nano’s cash value accrues to the benefit of Nano’s shareholders through their ownership in the combined company, not a SPAC sponsor.

A Rigorous Review and Diligence Process

The term sheet with Infinite is the culmination of a months-long, rigorous and comprehensive review process conducted with the support of Nano’s financial advisor and legal counsel. This review process considered a range of opportunities, including companies within the manufacturing space, as well as those operating in healthcare diagnostics, artificial intelligence, biological data analytics, and precision medicine. In addition, the Company engaged the services of several well-known consultants to assist in assessing Infinite’s technology, target markets and business operations.

Board Expertise and Independence

The Board is composed of individuals with significant experience across capital allocation, mergers & acquisitions, corporate governance, public markets and technology-enabled industries. The board remains committed to driving long-term returns for shareholders and has the ability, with the support of external experts and advisors, to evaluate complex opportunities and execute transactions that enhance shareholder value.

Additionally, Murchinson's reference to General Garrett conflates two fundamentally different roles. A director is a fiduciary who votes to approve a transaction; an advisor provides subject-matter expertise and has no vote, no fiduciary duty, and no authority over whether a deal proceeds or on what terms. General Garrett serves Infinite Epigenetics as an advisor on government and military health, a field unrelated to the matters Murchinson cites, and plays no role in Nano's evaluation or approval of this combination, which rests with Nano's Board and its shareholders. Attaching a prior, unanimous Board decision to an individual's later, unrelated advisory role is innuendo, not analysis.

Alignment with Shareholders

The Board rejects any implication that its decision to pursue this transaction is motivated by interests that are not aligned with shareholders. For the avoidance of doubt, the Board has not approved and will not support any arrangement that is not aligned with shareholder interests. Indeed, this transaction will not provide for any separate or transaction-driven compensation or payouts. The term sheet provides for Nano to get two board seats to join the combined company board based upon the expected shareholder ownership split; this is designed to protect the ongoing interests of Nano’s shareholders and is standard practice for all stock mergers.

We have heard from certain shareholders that they prefer a simple return of capital. That option is far less attractive than it appears. A liquidation or wind-down would not return the headline cash dollar-for-dollar: it would be reduced materially by wind-down and professional costs, tax leakage, reserves for contingent liabilities, and the time value of cash escrowed for an extended period before any final distribution. It would also assign zero value to Nano's Nasdaq listing, a scarce, expensive-to-replicate asset, and remove any chance of upside. By contrast, the proposed combination values Nano at net cash plus a 20% premium, preserving Nano’s listing's value, lets holders retain contingent value rights on Nano's legacy assets, and adds equity upside, a premium with optionality versus a discount with finality.

Transaction Terms

While we are not able to address particular terms of the merger until we have fully negotiated definitive documents, we believe the terms we have negotiated thus far are customary for transactions of this nature. Moreover, we are affording our shareholders the opportunity to receive a 20% premium for the cash value of the Company through the ownership in the combined entity.

Market Reaction vs. Long-term Outlook

Short-term trading volatility is not a reliable measure of long-term value creation as market reactions immediately following an announcement are often incomplete, information-constrained and influenced by short-term trading dynamics. The Board is committed to clear and consistent engagement with all investors and is confident that once the full and detailed information is available for review, investors will recognize the substantial value creation opportunity that this transaction represents. To that end, any definitive agreement will be presented and subject to shareholder vote. The Board does not make decisions focused on maximizing short-term price performance but rather aligned with strategies that they believe will generate superior long-term value creation for the Company’s shareholders.

Board Providing Transparency vs. Unclear Alternative From Murchinson

We agree with Murchinson that transparency is critical to maintaining credibility and the confidence of shareholders. Since Dave Stehlin was named CEO in September 2025 and the strategic review process was initiated, the Company has issued 13 press releases and updates where possible to ensure that the focus and strategy of the Board is clear. Our latest announcement, investor call, investor presentation and this subsequent press release are all testaments to the Board's commitment to provide information to shareholders as available so they can make an informed decision. While we acknowledge the importance of Murchinson's ability to ask questions, we believe the same standard of transparency should be applied equally to all parties. Murchinson has requisitioned an extraordinary shareholder meeting with intent to replace a majority of Nano's Board, yet despite multiple requests and offers for engagement, has not provided any detail on what their plan for Nano would be. On behalf of all shareholders, we ask: how would they utilize Nano's significant balance sheet reserves? The absence of any such transparency leaves shareholders without the information needed to evaluate whether Murchinson's intentions are aligned with the best interests of the Company and all of its shareholders.

Murchinson is asking shareholders to focus on surface-level labels. Nano is asking shareholders to look at the asset and value potential: a commercial epigenetics diagnostics platform with strong recurring revenue, a CLIA-certified lab, more than 120,000 epigenetic samples processed, over 50 peer-reviewed validation studies, reported performance metrics across major chronic diseases that are stronger than traditional diagnostics, one of the world’s largest proprietary biological datasets, and an AI foundation model that Nano’s capital can help accelerate toward significant revenue growth.

Nano’s cash is not being used to chase an AI slogan. It is expected to fund clinical validation, payer evidence, reimbursement work, provider growth, data infrastructure, regulatory preparation, pharma and data partnerships, and disciplined commercial scale.

About Nano Dimension Ltd.
Nano Dimension Ltd. (Nasdaq: NNDM) has historically delivered advanced digital manufacturing technologies serving customers across the defense, aerospace, automotive, electronics and medical device industry segments. Following a strategic review process initiated in 2025, the Company has focused on streamlining its operations, reducing cash burn, monetizing product lines and evaluating opportunities to deploy its capital base and publicly traded company platform into a more compelling long-term value creation opportunity. Nano Dimension continues to operate its remaining product lines, while the Company advances its strategic plan and evaluates the proposed business combination with Infinite Epigenetics. For more information, please visit www.nano-di.com.

About Infinite Epigenetics
Infinite Epigenetics is an AI-powered, preventive health and diagnostics company building a proprietary biological AI platform to read, interpret, and apply epigenetic signals at scale. Powered by one of the world’s largest private DNA methylation datasets and supported by a deep body of peer-reviewed research, the company partners with biotech innovators, researchers, and healthcare organizations to translate epigenetic insights into actionable diagnostic and clinical applications. Its operating portfolio includes TruDiagnostic™, a CLIA-certified laboratory and clinical epigenetic testing company, and Tally Health™, a consumer longevity and preventive health company. For more information, visit www. infiniteepigenetics.com.

infiniteepigenetics.com
trudiagnostic.com
tallyhealth.com
prnewswire.com/news/trudiagnostic

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements regarding the extraordinary general meeting requisitioned by Murchinson, Nano Dimension’s strategic plan, strategic alternatives review process, expectations on the timing, economics and success of the proposed business combination, beliefs regarding the future success and long-term growth opportunities of Infinite Epigenetics and the combined company, expectations for the structure of the proposed business combination, belief that deploying Nano’s capital and publicly traded company platform into a high growth healthcare and data business offers a more compelling path to long-term value creation than continuing to scale within the advanced digital manufacturing sector, and all other statements other than statements of historical fact that address activities, events or developments that Nano Dimension intends, expects, projects, believes or anticipates will or may occur in the future. Forward-looking statements may be characterized by terminology such as “believe,” “project,” “expect,” “anticipate,” “estimate,” “forecast,” “outlook,” “target,” “endeavor,” “seek,” “predict,” “intend,” “strategy,” “plan,” “may,” “could,” “should,” “will,” “would,” “continue,” “likely,” or the negative thereof or variations thereon or similar terminology generally intended to identify forward-looking statements. Such statements are based on management’s beliefs and assumptions made based on information currently available to management. These forward-looking statements involve known and unknown risks and uncertainties, which may cause the Company’s actual results and performance to be materially different from those expressed or implied in the forward-looking statements. Accordingly, the Company cautions shareholders that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, estimates and uncertainties that are difficult to predict. The forward-looking statements contained or implied in this communication are subject to other risks and uncertainties, including, but not limited to (i) the risk that Nano Dimension and Infinite Epigenetics are unable to negotiate and enter into a definitive agreement for the proposed combination; (ii) the risk that the conditions to the closing (including any necessary shareholder approvals) are not satisfied; (iii) uncertainties as to the timing of the consummation of the proposed combination and the ability of each of Nano Dimension and Infinite Epigenetics to consummate the proposed combination; (iv) effect of the announcement of the proposed combination on the ability of Nano Dimension and Infinite Epigenetics to continue to operate their respective businesses and retain and hire key personnel and to maintain favorable business relationships; (v) risks related to the failure or delay in obtaining required approvals from any governmental or regulatory entity necessary to consummate the proposed combination; (vi) changes in the exchange ratio that could cause Nano Dimension’s shareholders and Infinite Epigenetics’ stockholders to own more or less of the combined company than is currently anticipated; (vii) risks related to the market price of Nano Dimension’s shares relative to the value suggested by the term sheet; (viii) unexpected costs, charges or expenses resulting from the proposed combination; (ix) the potential for the occurrence of any event, change or other circumstance or condition that could give rise to the termination of the definitive agreement for the proposed combination and the other agreements entered into in connection therewith; (x) the possibility that holders of CVRs may never receive any proceeds therefrom; (xi) changes in demand for Nano Dimenson’s or Infinite Epigenetics’ products and services; (xii) global market, political and economic conditions, and conditions in the countries in which Nano Dimension and Infinite Epigenetics operate; (xiii) the impact of changes in law and government regulations; (xiv) competition in the epigenetics health industry; (xv) the risk of litigation, including any proceedings that may be instituted against Nano Dimension or Infinite Epigenetics related to the proposed combination; (xvi) the impact of rapid technological change in the epigenetics health industry; and (xvii) those discussed under the heading “Risk Factors” in Nano Dimension’s annual report on Form 10-K for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 31, 2026, and in any subsequent filings with the SEC.

Except as otherwise required by law, Nano Dimension undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this communication.

Additional Information and Where to Find It
The Company has filed a preliminary proxy statement and intends to file a proxy statement and WHITE proxy card with the SEC in connection with its solicitation of proxies for an extraordinary general meeting of shareholders that will include, among other proposals, a proposal to approve on a non-binding advisory basis a resolution regarding the continuation of Nano Dimension’s strategic alternatives review process including any related transaction approved by the Board (the “Extraordinary General Meeting”). THE COMPANY’S SHAREHOLDERS ARE STRONGLY ENCOURAGED TO READ THE DEFINITIVE PROXY STATEMENT, ANY AMENDMENTS OR SUPPLEMENTS THERETO, AND THE ACCOMPANYING WHITE PROXY CARD WHEN THEY BECOME AVAILABLE, AS THEY WILL CONTAIN IMPORTANT INFORMATION.

Shareholders may obtain the proxy statement, any amendments or supplements to the proxy statement and other documents as and when filed by the Company with the SEC without charge from the SEC’s website at www.sec.gov.

This communication also relates to a proposed combination involving Nano Dimension and Infinite Epigenetics and may be deemed to be solicitation material in respect of the proposed combination. In connection with the proposed combination, Nano Dimension intends to file with the Securities and Exchange Commission (the “SEC”) a registration statement on Form S-4 that will contain a proxy statement of Nano Dimension that will constitute a prospectus with respect to shares of Nano Dimension’s stock to be issued in the proposed combination (the “Proxy Statement/Prospectus”). Nano Dimension may also file other documents with the SEC regarding the proposed combination. This document is not a substitute for the Proxy Statement/Prospectus or any other document which Nano Dimension may file with the SEC. INVESTORS AND SECURITYHOLDERS OF NANO DIMENSION AND INFINTE EPIGENETICS ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS THAT WILL BE FILED BY NANO DIMENSION WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED COMBINATION AND RELATED MATTERS. Nano Dimension shareholders and Infinite Epigenetics stockholders will also be able to obtain free copies of the Proxy Statement/Prospectus (when available) and other documents containing important information about Nano Dimension, Infinite Epigenetics and the proposed combination that will be filed with the SEC by Nano Dimension through the website maintained by the SEC at www.sec.gov. Copies of the documents filed with the SEC by Nano Dimension will also be available free of charge on Nano Dimension’s website at https://investors.nano-di.com/sec-filings-1/default.aspx or by contacting Nano Dimension’s investor relations department by email at [email protected].

Participants in the Solicitation
The Company, the President, Chief Executive Officer and Director, David Stehlin, and each of its non-employee directors (namely, Robert Pons; Phillip Borenstein; Dr. Joshua Rosensweig and Andrew Sriubas) are deemed to be “participants” (as defined in Section 14(a) of the Securities Exchange Act of 1934) in the solicitation of proxies from the Company’s shareholders in connection with the matters to be considered at the Extraordinary General Meeting. Information about the compensation of our non-employee Directors is set forth in the sections titled “Director Compensation” and “Director Compensation Table” in the Company’s Annual Report, at pages 54-56, and is available here. Information about the compensation of our President, Chief Executive Officer, and Director, David Stehlin, is set forth in the section titled “Executive Compensation” in the Annual Report, at pages 56-64, and is available here. Information regarding the participants’ holdings of the Company’s securities can be found in the section titled “Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters” in the Company’s Annual Report on pages 64-65 and is available here, and as updated in the filings referenced below. Supplemental information regarding the participants’ holdings of the Company’s securities can be found in SEC filings on Statements of Change in Ownership on Form 4 filed with the SEC on May 29, 2026 for Mr. Stehlin (available here) and June 12, 2026 (available here). Such filings are available on the Company’s website at https://investors.nano-di.com/sec-filings-1/default.aspx or through the SEC’s website via the links referenced above.

Updated information regarding the participants’ direct or indirect interests, by security holdings or otherwise, is be set forth in the Company’s preliminary proxy statement on Schedule 14A and will be set forth in the Company’s definitive proxy statement and other materials to be filed with the SEC in connection with the Extraordinary General Meeting.

Nano Dimension and its directors and executive officers may be deemed to be “participants” (as defined in Section 14(a) of the Securities Exchange Act of 1934) in the solicitation of proxies from Nano Dimension’s shareholders in connection with the proposed combination. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies from Nano Dimension’s shareholders in connection with the proposed combination will be set forth in the Proxy Statement/Prospectus on Form S-4 for the proposed combination, which is expected to be filed with the SEC by Nano Dimension. Investors and securityholders of Nano Dimension and Infinite Epigenetics are urged to read the Proxy Statement/Prospectus and other relevant documents that will be filed with the SEC by Nano Dimension carefully and in their entirety when they become available because they will contain important information about the proposed combination.

Contacts

Investors:
Purva Sanariya
Director, Investor Relations
[email protected]

Media:
Samuel Manning
Principal Manager, External Communications
[email protected]

Robinhood Markets will lay off about 10% of its workforce, representing roughly 290 jobs, aiming to cut costs and work more efficiently.

The LayoffsAccording to an SEC filing, Robinhood announced the workforce reduction on June 16 as part of efforts to “maintain a high performance culture, further accelerate product velocity and remain lean and disciplined.” The company said it is taking the action from a position of business strength, noting that June month-to-date average daily trading volumes are at record levels across equities, options and prediction markets.

The reduction also involves the closure of a small number of open roles across the company. Robinhood estimates it will incur approximately $20 million in cash restructuring charges related to employee severance and benefits, as well as approximately $8 million in share-based compensation charges. The company expects to recognize the accrual for these charges in the second quarter of 2026.

Robinhood Shares Edge HigherHOOD Price Action: At the time of publication, Robinhood shares are trading 2.17% higher at $100.25, according to data from Benzinga Pro.

Image via Shutterstock

This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

Robinhood Markets said on Tuesday it will reduce its full-time workforce by roughly 10%, affecting about 290 employees, as part of a restructuring effort that comes despite record trading activity across several of its businesses.

The online trading platform also said it would eliminate a small number of remaining open positions.

Shares of Robinhood HOOD rose about 2.5% in premarket trading following the announcement.

In a regulatory filing, the company said it expects to incur approximately $20 million in restructuring charges related to employee severance and benefits, along with roughly $8 million in share-based compensation expenses.

The charges are expected to be recognized during the second quarter.

"The company is taking this action from a position of business strength, including June month-to-date average daily trading volumes at record levels across equities, options, and prediction markets," Robinhood said.

Robinhood had approximately 2,900 full-time employees at the end of December, according to its latest filings with the US Securities and Exchange Commission.

The workforce reduction comes as Robinhood continues to benefit from elevated trading activity and growing customer engagement.

The company reported first-quarter results in April, showing modest profit growth and a 15% increase in revenue, driven by strong activity in options trading, subscription products, and prediction markets.

Management also indicated at the time that the second quarter had begun strongly, supported by robust trading volumes across its platform.

The latest filing reinforced that message, with Robinhood highlighting record average trading activity across equities, options, and prediction markets during June.

The company has increasingly positioned itself as a broader financial platform rather than simply a commission-free stock trading app, expanding into retirement products, subscriptions, and event-based trading.

One area attracting particular attention from analysts is Robinhood's rapidly growing prediction markets business.

Analysts at Bernstein said the company could see significant benefits from a surge in activity tied to the FIFA World Cup.

According to the research firm, daily prediction market volumes rose from $2.2 billion on June 11 to $4.8 billion on June 12, when the United States played Paraguay.

Bernstein noted that those figures already exceed the approximately $1.4 billion traded during last season's Super Bowl.

In a note to clients, analysts led by Gautam Chhugani said prediction markets have become Robinhood's fastest-growing revenue-generating product since launch.

The brokerage forecasts revenue from prediction markets will rise from $150 million in 2025 to $586 million in 2026, representing a growth of 286% year over year.

If realized, prediction markets would account for roughly 17% of Robinhood's transaction-based revenue and about 10% of the overall company revenue next year.

Robinhood's workforce reduction also reflects a broader trend across the technology sector.

Companies including Snap, Block, Atlassian, and Pinterest have announced significant layoffs this year as firms seek to improve efficiency while investing in new technologies.

According to data from Challenger, Gray & Christmas, technology companies announced 38,242 job cuts in May alone.

Year-to-date reductions have reached 123,653 positions, a 66% increase from the same period last year.

At the same time, technology remains the leading source of hiring plans, with employers announcing more than 11,000 planned hires in May, underscoring the sector's continued growth even as companies reshape their workforces.

By You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.

Robinhood is cutting 10% of its staff amid an organizational "flattening." Taylor Hill/FilmMagic Robinhood, the stock-trading app that became synonymous with the pandemic-era's retail-investing boom, is cutting 10% of its workforce and joining tech's "Great Flattening."

CEO Vlad Tenev told employees in a memo on Tuesday that the company's business "has never been stronger," but said Robinhood needed to become leaner as it scales. Tenev said the company was "flattening" its organizational structure and reducing head count to avoid becoming a "heavily-layered organization."

In an SEC filing on Tuesday, Robinhood said the cuts come as June's month-to-date average daily trading volumes hit record levels across equities, options, and prediction markets. In a February filing, the company reported having 2,900 full-time staff as of December 31, 2025.

In his memo, Tenev wrote that the company will "continue hiring strategically," while investing in "top-tier talent" and using "frontier technologies."

Affected employees were being notified on Tuesday, he said. The company declined to provide additional comment, and Robinhood didn't specify what teams are affected by the cuts in the memo.

Robinhood is the latest to join tech's "Great Flattening," or the slashing of middle layers in an effort to reduce bureaucracy and move faster. In the wake of the pandemic-era hiring boom, several household-name companies — including Microsoft, Google, Amazon, and Meta — have thinned out management ranks and leaned into individual contributors as they make their org charts flatter.

Read the memo Robinhood's CEO sent to staff:Robinhoodies,We've made the difficult decision to say goodbye to some of our team members today. Those departing are being notified, and we're offering them full support through this transition, including severance. These are good people who helped build the foundation we stand on today, and I am deeply grateful for their contributions to Robinhood.

I want to be transparent about why this is happening now. Robinhood's business has never been stronger. But to achieve the massive scale of our mission, we cannot default to operating as a heavily-layered organization. We must be a lean, hyper-focused team where every single individual is empowered to make a massive impact. Our execution is strong today, but our ambitions require us to continuously raise our own bar. To achieve that, today we are flattening our org structure and reducing our overall team size by 10% of headcount.

Because our financial position is strong, we are making this change proactively. The goal is to maximize our talent density and ensure that our culture is defined by an absolute elite performance bar and a superlative commitment to our customers. This transition creates even more opportunities for our most talented people to grow and take on greater responsibility. We will also continue hiring strategically, investing heavily in top-tier talent, and utilizing frontier technologies to push our execution even further.

I know it can be painful to say goodbye to teammates. It is the hardest consequence of committing uncompromisingly to our values of being "Lean & Disciplined" and demanding "High Performance."

Read next

Ben Shimkus You're currently following this author! Want to unfollow? Unsubscribe via the link in your email.

Ben Shimkus is a reporter for the Business News desk. He writes about cars, transportation, retail, and jobs. Ben's reporting has appeared in Rolling Stone, The Verge, Automotive News, USA Today, AutoBody News, LGBTQ Nation, TopSpeed, and Out Magazine. He's also held staff writing positions at The U.S. Sun and the Daily Mail. He graduated from NYU with a Master's in journalism in 2024. Email Ben at [email protected] or message him privately on Signal at bshimkus.41. 

Layoffs Tech

Robinhood Markets Inc (NASDAQ:HOOD) announced on Tuesday that it will reduce its full-time workforce by approximately 10%, or about 290 positions, as the online brokerage seeks to streamline operations and flatten its organizational structure.

The company disclosed the layoffs in a regulatory filing, describing the move as part of an effort to maintain operational efficiency despite strong business performance.

According to the filing, the restructuring is expected to result in approximately $20 million in cash-related costs and $8 million in equity compensation expenses, which will be recognized in the second quarter of 2026.

In a message shared with employees and later posted on the social media platform X, Robinhood CEO Vlad Tenev said the company was making the changes proactively rather than in response to financial pressures.

“Robinhood’s business has never been stronger,” Tenev wrote. “But to achieve the massive scale of our mission, we cannot default to operating as a heavily-layered organization.”

Tenev said the company aims to operate as a leaner organization where employees are empowered to make a greater impact.

He added that the restructuring is intended to increase "talent density" and reinforce a culture focused on performance and customer service.

The CEO also noted that Robinhood plans to continue hiring selectively and investing in top talent and emerging technologies.

The layoffs come as Robinhood reports record average daily trading volumes across stocks, options, and prediction markets, according to the company.

Employees affected by the cuts will receive severance and other support during the transition, Tenev wrote.

Shares of Robinhood were up 0.6% at about $99 on Tuesday morning, having fallen about 13% so far this year.  

It appears using AI as a cover story for cutting jobs is fast falling out of fashion.

Unlike many of his tech industry peers who have cut thousands of jobs this year citing the need to restructure their teams to make the most of AI, Robinhood’s CEO Vlad Tenev conspicuously made no mention of AI in his note to employees announcing that the company is letting go 10% of its full-time employees, or about 290 people.

Nor did the company’s regulatory filing announcing the move, which instead framed the cuts as a restructuring exercise.

Still, Tenev did say the company would use “frontier technologies to push our execution even further,” which sounds like a conscious effort to avoid even naming AI. Which isn’t surprising: Sentiment against AI and related infrastructure projects has been trending lower even as a small minority of tech executives make ridiculous bank.

But Tenev did add to the ongoing narrative that it’s now necessary for companies to operate with smaller teams and “flatter organizational structures,” writing: “We ⁠cannot default to operating as a heavily-layered organization. We must be a lean, hyper-focused team where every single individual is empowered to make a massive impact.”

We’ve seen companies of various stripes, from Amazon, Block, Coinbase, GitLab, and Intuit employing similar language in their layoff announcements, indicating that large teams, bureaucracy, and siloed departments are now seen as undesirable line items at a time when AI tools promise to significantly improve productivity.

Some even think it’s a tacit allusion to the fact that tech companies over-hired following the COVID-19 pandemic, and are now scaling back as expenses begin to pile up — especially those associated with massive AI usage.

Regardless, these companies are doing quite well. Tech stocks have surged broadly, spurred by record revenues, improving profit margins (GitLab reported 88% gross margin last month), skyrocketing demand for cloud services, and the belief that the billions being poured into data center projects will produce returns that are orders of magnitudes higher.

Robinhood itself reported a 15% improvement in first-quarter revenue in April, and the company said its second quarter is looking better thanks to rising prediction market fees, subscription revenue, and strong equity and option-trading volumes as markets stabilize.

The company said on Tuesday it is also closing “a small number” of open roles, and that it would incur about $28 million in costs related to the cuts.

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.

Ram is a financial and tech reporter and editor. He covered North American and European M&A, equity, regulatory news and debt markets at Reuters and Acuris Global, and has also written about travel, tourism, entertainment and books.

You can contact or verify outreach from Ram by emailing [email protected].

watch now

Sports prediction markets are having a gold-rush moment. Enthusiasm around the World Cup and NBA finals led Kalshi to set a new daily record Saturday for trading volume at $1.2 billion.

A wave of companies is trying to stake a claim, hoping to follow suit and strike it rich in what JB Mackenzie, Robinhood's head of prediction markets, described to CNBC as a "supercycle."

He points not only to a packed sports summer calendar leading directly into NFL season and midterm elections, but a jammed pipeline of companies applying to the Commodity Futures Trading Commission to become designated contract markets, or DCMs.

On Tuesday, the CFTC granted approval for Novig's DCM application. ProphetX's was approved a week earlier. But both companies will be up against not only Kalshi, which dominates the space, but Polymarket, Robinhood, Crypto.com and the sportsbook giants FanDuel, DraftKings and Fanatics.

Novig is trying to differentiate itself with a sports-first pitch. The company, founded by Jacob Fortinsky and Kelechi Ukah, says it has received CFTC approval to operate as a federally regulated prediction market focused on sports.

Fortinsky told CNBC the company is building a peer-to-peer sports trading platform that allows users to trade directly against one another rather than bet against the house.

"What we're doing is basically cutting out the middle man," Fortinsky said. "We're really rendering sportsbooks obsolete."

Fortinsky argues that traditional sportsbooks are structurally misaligned with customers because they act as the counterparty to wagers. In Novig's model, he said, the platform is agnostic to the outcome of a game and makes money from trading activity rather than customer losses.

The company is moving its entire business into the CFTC-regulated prediction-market category, he said. Previously, it operated in Colorado under a state sports-betting license, but then pivoted to a sweepstakes-based product before pursuing the federal exchange model. It will maintain an age limit of 21+.

It has a large war chest for a young startup. Novig raised a $75 million Series B in February led by Pantera Capital, with participation from investors including Forerunner Ventures, NFX, Multicoin Capital, Makers Fund and others, according to the company. Forbes reported the round valued Novig at $500 million, and brought total capital raised to more than $105 million.

Novig says it has done more than $5 billion in cumulative volume and more than $8 billion in annualized volume, driven by what Fortinsky describes as sports fans increasingly approaching games like a tradable asset class.

"People, sports traders, are becoming more price sensitive," Fortinsky said. "They're increasingly looking at sports as an asset class."

A crowded fieldBut Novig is entering a field where the race to claim first-mover status is already crowded.

ProphetX said earlier this month that the CFTC approved its applications to register as both a designated contract market, which is an exchange, and a derivatives clearing organization, which clears trades.

ProphetX CEO and co-founder Dean Sisun said the approval "positions ProphetX to become the first sports-native direct-clearing prediction market in the United States."

The company's claim is that it will offer sports event contracts and build a sports-native exchange and clearing structure under the CFTC framework.

Fortinsky argues Novig is built natively around the sports trader, with a product and technology stack designed for exchange-based sports trading rather than adapted from sportsbook infrastructure or general-purpose prediction markets.

The competition is not limited to exchanges.

Betr, the real-money gaming company founded by Joey Levy and YouTube star and boxer Jake Paul, is taking a distribution-first approach. The company acquired Ascent Capital Management, a National Futures Association-registered introducing broker, to accelerate its launch of prediction markets powered by Polymarket.

Levy told CNBC that Betr's advantage is breadth.

"We are the first super app in the space offering picks, Sportsbook, casino, arcade, and soon prediction markets all in one app with one wallet," Levy said. "So yes we think we can take on FanDuel, DraftKings, Kalshi, etc. given we are offering more content overall and have that differentiated experience."

Levy added that Betr is seeing "explosive revenue growth" while growing "efficiently and profitably."

Robinhood brings another model: brokerage distribution, giving event contracts exposure to consumers who already think in terms of trading, probabilities and market prices rather than traditional betting slips.

Crypto.com is playing an infrastructure role. FanDuel Predicts announced an expanded event-contract offering through Crypto.com's CFTC-regulated exchange and clearinghouse, OG Prediction Markets, broadening the types of sports and entertainment markets available to customers. That gives FanDuel a way to participate in prediction markets without immediately becoming the exchange itself.

DraftKings has also moved into prediction markets, framing the category as complementary to its sportsbook business rather than a replacement. The company reported DraftKings Predictions had its biggest weekend yet. "Driven by the NBA Finals and the start of the World Cup, total customers grew over 200% compared to the prior weekend," the company said in a news release.

Fanatics is another major sportsbook operator watching the space closely as sports trading moves from niche prediction markets toward mainstream wagering behavior.

For the sportsbook giants, the threat is obvious. They already have the customers, brands, promotions and state-by-state gaming infrastructure. But sports prediction markets challenge the basic sportsbook model by offering prices that look more like financial markets and products that may be available nationally under federal oversight.

Sports trading as an asset classThe legal fight is intensifying. Multiple states and tribes are suing Kalshi and others arguing they're breaking the law by facilitating unlicensed gambling.

Kalshi continues to insist prediction markets are regulated by the CFTC.

The agency joined the legal fray to defend its federal oversight filing a suit this week against New Mexico in the state's attempt to apply gaming law to prediction markets.

The CFTC has proposed rules that would generally allow sports event contracts, while restricting categories tied to injuries, officiating decisions, high school sports, fights, war, terrorism and other events the agency views as sensitive or easily manipulated.

Fortinsky said he believes sports trading should be treated as a legitimate asset class.

"Sports is just as legitimate of an asset class as crypto, as other types of futures," he said.

If sports prediction markets are treated as swaps or event contracts, they could scale nationally through federal regulation. If courts or lawmakers decide they are functionally sports bets, they could be pushed back into the state-by-state gaming system.

The prize is large enough to explain the rush. Sports offer the ingredients prediction markets need: constant events, passionate fans, live volatility, media attention and a steady supply of outcomes that can be priced in real time.

But the competition for customers and their dollars is fierce. Some industry insiders are already questioning how many sports prediction platforms the market can support once the early rush gives way to a fight for volume, pricing and regulatory durability.

In prediction markets, liquidity can compound quickly. Traders go where the markets are deepest. Kalshi's weekend volume shows what dominance looks like when liquidity concentrates.

Prediction market volumes surged over the weekend, according to Piper Sandler analyst Patrick Moley, with Kalshi posting $3.38 billion in volume, up 35% month over month. Kalshi confirmed the figures to CNBC. Moley says Polymarket totaled $1.41 billion, up 33% month over month, though Polymarket U.S. volumes from Sunday had not yet been released. Rothera, the CFTC-regulated prediction market exchange that has a partnership with Robinhood, did $131.4 million in volume over the weekend and Friday.

Though exchanges report weekend activity differently, they illustrate how concentrated the category has already become. Kalshi's weekend volume was roughly 2.4 times Polymarket's reported total and more than 25 times Rothera's.

For Novig, ProphetX, Betr and the next wave of entrants, the question is whether they can create enough differentiated liquidity, product design and consumer trust to carve out space — before the biggest exchanges, sportsbooks and brokers define the market for them.

—CNBC's Jessica Golden and Davis Giangiulio contributed reporting.

Disclosure: CNBC and Kalshi have a commercial relationship which includes customer acquisition and a minority investment.

Correction: Rothera has a partnership with Robinhood. A previous version mischaracterized the relationship between the two entities.

Novig's $75 million Series B funding was led by Pantera Capital, and included other investors such as Forerunner Ventures, NFX, Multicoin Capital, Makers Fund and others. A previous version of the story misstated the names of the investors.

By PYMNTS  |  June 16, 2026

 | 

Financial platform Robinhood Markets says it is laying off 10% of its staff.

The job cuts are part of the company’s “efforts to maintain a high performance culture, further accelerate product velocity, and remain lean and disciplined,” Robinhood said in a Tuesday (June 16) Securities and Exchange Commission (SEC) filing.

The filing added that Robinhood “is taking this action from a position of business strength, including June month-to-date average daily trading volumes at record levels across equities, options and prediction markets.”

A report on the cuts by the Wall Street Journal (WSJ) said the layoffs, which will eliminate around 290 jobs, are Robinhood’s first cuts in three years. The report also cited a note to employees from CEO Vlad Tenev who said Robinhood’s business has never been stronger.

“It is the hardest consequence of committing uncompromisingly to our values of being ‘lean & disciplined’ and demanding ‘high performance,’” Tenev wrote.

Robinhood reported a 15% increase in revenue during its most recent earnings, although its stock dipped as that figure fell short of analyst expectations.

Advertisement: Scroll to Continue

“The most striking feature of the quarter was not the revenue miss itself but the reshuffling of where that revenue comes from,” PYMNTS wrote at the time.

“Historically, Robinhood’s growth engine was powered by transaction-based activity, and especially cryptocurrency trading. That engine is now sputtering, with crypto trading revenue plunging roughly 47% year over year.”

In its place, two newer revenue sources have stepped into the limelight: subscription services and prediction markets.

This shift, PYMNTS added, marks a major evolution for the company, as it moves from being simply a brokerage to “a hybrid platform where investing, speculation and entertainment can increasingly blur.”

That evolution continued last week when Tenev announced Robinhood could now serve as an underwriter for initial public offerings (IPOs).

Tenev also announced in May that Robinhood’s first fund, aimed at giving retail investors greater access to private markets, had attracted 150,000 customers.

“It’s also just the beginning,” Tenev said in a speech at the WSJ’s Future of Everything event.

“The aspiration is, if you’re a company raising a seed round and a Series A round, so just first capital, retail should be a big chunk of that round, much like it now is in the public markets, and we should let those people in at the ground floor so that they can actually benefit from this potential appreciation that’s increasingly happening in the private markets.”

For all PYMNTS B2B coverage, subscribe to the daily B2B Newsletter.

Robinhood's (HOOD 1.44%) stock closed at a record high of $152.46 per share on Oct. 9, 2025. It had more than quadrupled from its IPO price of $38 in July 2021. The ongoing bull market, which began in 2022, was attracting new users and boosting its revenues.

But as of this writing, Robinhood's stock trades at about $97. While we're still firmly in a bull market, concerns about inflation, the Middle East conflict, and potential interest rate hikes are all driving investors toward more conservative investments. That lower trading volume will likely discourage active trading and throttle Robinhood's growth. The S&P 500 also looks expensive at nearly 30 times earnings -- so the next bear market could be right around the corner.

Image source: Getty Images.

Those fears pulled Robinhood's stock down from its all-time highs, but could it skyrocket and set new highs in the next bull market? Let's review its longer-term catalysts to find out.

How fast is Robinhood growing? Robinhood disrupted traditional brokerages by offering commission-free trades on its streamlined app. From 2020 to 2025, its annual revenue surged from $959 million to $4.5 billion, while its total funded customers more than doubled from 12.5 million to 27.0 million. Many of those customers were younger, first-time investors with smaller accounts.

Robinhood also ended 2025 with 4.2 million Gold subscribers, who pay $5 a month (or $50 annually) for interest-free margin, lower margin rates, higher interest rates on uninvested cash, and other perks. That represented 58% growth from the end of 2024.

Today's Change

(

-1.44

%) $

-1.41

Current Price

$

96.71

Robinhood is firmly profitable, and its adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) -- which tunes out the noise from its recent acquisitions, stock-based compensation, and other one-time expenses -- turned positive in 2023, rose 167% in 2024, and grew another 76% to $2.5 billion in 2025. That bottom-line growth was driven by higher interest rates, higher fees from crypto and options trades, and Robinhood Gold's expansion.

How much higher could its stock go? From 2025 to 2028, analysts expect Robinhood's revenue and adjusted EBITDA to both grow at CAGRs of about 15%. With an enterprise value of $82 billion, it might seem a bit pricey at 32 times this year's adjusted EBITDA. Still, its popularity among younger investors, its growth in Gold memberships, and its expanding fintech ecosystem (including prediction markets trading) could justify that higher valuation.

It's impossible to tell when the next bear and bull markets will happen, but Robinhood is a resilient company that has already endured several boom-and-bust cycles since its 2021 IPO. If it matches analysts' estimates and maintains its EV/EBITDA ratio through 2028, its stock could easily rise by more than 50% over the next two years.

In the latest close session, Monday.com (MNDY - Free Report) was down 2.2% at $75.56. The stock's performance was behind the S&P 500's daily loss of 0.57%. Meanwhile, the Dow experienced a rise of 0.64%, and the technology-dominated Nasdaq saw a decrease of 1.15%.

Prior to today's trading, shares of the project management software developer had lost 1% lagged the Computer and Technology sector's gain of 2.85% and the S&P 500's gain of 2.14%.

The upcoming earnings release of Monday.com will be of great interest to investors. The company is expected to report EPS of $1.14, up 4.59% from the prior-year quarter. Simultaneously, our latest consensus estimate expects the revenue to be $354.95 million, showing a 18.71% escalation compared to the year-ago quarter.

For the full year, the Zacks Consensus Estimates project earnings of $4.49 per share and a revenue of $1.47 billion, demonstrating changes of +2.05% and +19.34%, respectively, from the preceding year.

Any recent changes to analyst estimates for Monday.com should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Currently, Monday.com is carrying a Zacks Rank of #3 (Hold).

In terms of valuation, Monday.com is currently trading at a Forward P/E ratio of 17.23. This indicates a discount in contrast to its industry's Forward P/E of 18.65.

We can also see that MNDY currently has a PEG ratio of 1.37. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. By the end of yesterday's trading, the Internet - Software industry had an average PEG ratio of 1.05.

The Internet - Software industry is part of the Computer and Technology sector. This industry currently has a Zacks Industry Rank of 93, which puts it in the top 39% of all 250+ industries.

The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.

Two of the largest asset managers on Wall Street are rewriting the rules of AI infrastructure financing, and the deal they just made public is sure to have a substantial impact on the industry as a whole. What does it mean in particular for Micron (MU 5.50%) and Nvidia (NVDA 2.16%), two of the biggest winners of the AI build-out thus far? 

Today's Change

(

-2.16

%) $

-4.59

Current Price

$

207.86

The money keeps pouring into AI Apollo Global Management (APO +1.74%) and Blackstone (BX +2.60%) finalized a $35 billion financing deal to aid Anthropic in its expansion efforts. The agreement is one of the largest private credit deals ever.

The deal is structured using a Special Purpose Vehicle (SPV) to purchase Tensor Processing Units (TPUs) from Alphabet's Google. Those will then be leased to Anthropic. Through this structure, Anthropic will keep the hardware off its balance sheet. This will be a useful financial tool as Anthropic prepares for its initial public offering. Those TPUs will be deployed in data centers starting sometime this year and will expand Anthropic's compute capacity by 1 gigawatt (GW).

Broadcom is also an integral part of the deal and is providing a crucial credit endorsement through residual value guarantees for $30 billion in debt tranches. Apollo's Atlas SP Partners contributed an additional $800 million in equity.

Broadcom CEO Hock Tan explained that the company is building an "AI XPV platform" with Apollo, Blackstone, and other top investors to deploy over 20 GW of compute through 2028 for both Anthropic and OpenAI.

Image source: The Motley Fool.

Nvidia's making room at the top This isn't a great deal for Nvidia. The entire agreement is built on Google TPUs, not Nvidia's GPUs. Anthropic is deepening its relationship with Google. Will this ruin Nvidia's dominance? Absolutely not, but it does carve out space for another winner.

Micron, on the other hand, could benefit tremendously. Regardless of which company's accelerators are providing the computing capacity, AI data centers can't operate effectively without scads of high-bandwidth memory. Micron is one of just three companies that can make it at scale. As the GPU versus TPU debate continues, Micron won't have to pick a side. It will supply memory to both. As such, this deal should be yet another boon for Micron's shareholders.

Today's Change

(

-5.50

%) $

-59.79

Current Price

$

1028.20

The AI build-out will require an additional $1.5 trillion in outside financing through 2028, according to Morgan Stanley. Private credit will undoubtedly play a major role. This Apollo and Blackstone deal is just the beginning and truly a template for what is to come in terms of innovative deal structures. Investors in companies such as Nvidia and Micron should take away two things: Competition among semiconductor companies is intense, and the demand for memory is only increasing.

Catie Hogan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, Blackstone, Broadcom, Micron Technology, and Nvidia. The Motley Fool has a disclosure policy.

On June 16, 2026, we conduct a DCF analysis for CME Group Inc CME , which has shown mixed price performance recently. The stock has increased by 6.1% over the past week but has decreased by 10.5% in the last month. Year-to-date, it has only gained 0.3%, and over the past year, it has risen by 2.6%. Here are some key points from our analysis:

DCF Earnings-based intrinsic value of $193.55 vs current price of $266.08 (margin of safety: -37.5%) DCF FCF-based intrinsic value of $189.44 vs current price (second opinion shows -40.5% margin of safety) GF Score™ of 88/100 indicates strong reliability of the DCF inputs What Is CME Worth? DCF Earnings-Based Model The DCF earnings-based model for CME Group Inc uses a two-stage growth approach. In the first stage, we project earnings growth for the next ten years, followed by a terminal phase where growth stabilizes. The assumptions for this model are summarized in the table below:

Parameter Value Current EPS (TTM, excl. non-recurring) $11.77 10-Year Growth Rate 10.4% 10-Year Treasury Rate 4.44% Discount Rate (ceil(Treasury) + 6%) 11% Terminal Growth Rate 4% In the first stage (Years 1-10), we expect EPS to grow at 10.4% annually, discounted at a rate of 11%. The value derived from this growth stage is $114.26 per share. In the second stage (Years 11-20), we assume a terminal growth rate of 4%, also discounted at 11%, resulting in a terminal stage value of $79.29 per share. The calculation summary is as follows:

Stage Description Value Growth Stage (Years 1-10) EPS growing at 10.4%, discounted at 11% $114.26 Terminal Stage (Years 11-20) 4% terminal growth, discounted at 11% $79.29 Intrinsic Value Growth + Terminal $193.55 Comparing the current price of $266.08 with the intrinsic value of $193.55 indicates that CME is modestly overvalued, with a margin of safety of -37.5%. It is important to note that GuruFocus uses EPS excluding non-recurring items, as research shows stock prices correlate more closely with earnings than free cash flow. For more detailed calculations, visit the CME DCF Calculator.

What Does the Free Cash Flow DCF Say? The free cash flow (FCF) based intrinsic value for CME Group Inc is calculated at $189.44. When compared to the earnings-based intrinsic value of $193.55, both models suggest that CME is modestly overvalued, with the FCF model indicating a margin of safety of -40.5%. This reinforces the notion that the stock is trading above its intrinsic value based on both earnings and cash flow assessments.

How Does GF Value™ Compare to the DCF Models? The GF Value™ for CME Group Inc is calculated at $270.47, providing a third perspective on the valuation. GF Value™ is GuruFocus' proprietary measure derived from historical trading multiples, past business growth, and future performance estimates. While the DCF models indicate that CME is overvalued, GF Value™ suggests a slight undervaluation. This discrepancy highlights the importance of considering multiple valuation methods. For more information, visit the GF Value™ page.

What Does CME's GF Score™ Tell Us? The GF Score™ ranks stocks from 0 to 100 based on five key aspects: Financial Strength, Profitability, Growth, Valuation, and Momentum. Stocks with higher GF Score™ values have been found to generate higher long-term returns based on backtested data from 2006-2021. The GF Score™ for CME is 88/100, indicating strong fundamentals. The table below summarizes the key metrics:

Metric Rating GF Score™ 88/100 Financial Strength 5/10 Profitability 8/10 Growth 10/10 Valuation 9/10 Momentum 4/10 The predictability rank for CME is 2/5 stars, indicating that the DCF model may be less reliable for this stock due to its lower predictability. For further insights, visit the CME stock page.

Key Assumptions and Limitations It is important to note that DCF models are highly sensitive to the assumptions made regarding growth rates and discount rates. Stocks with low predictability ratings, such as CME's 2/5 stars, tend to produce less reliable DCF estimates. Additionally, the terminal growth rate of 4% is a simplifying assumption that may not reflect future market conditions.

What This Means for Investors In summary, all three valuation models—DCF earnings, DCF FCF, and GF Value™—suggest that CME Group Inc is currently overvalued. The earnings-based intrinsic value is $193.55, the FCF-based intrinsic value is $189.44, and the GF Value™ is $270.47, indicating a range of perspectives on the stock's valuation. Overall, the consensus points towards CME being overvalued at its current price of $266.08. For the full DCF analysis, visit the CME DCF Calculator. You can also explore the GF Value™ page, or use the GuruFocus Stock Screener to find undervalued predictable companies.

Frequently Asked Questions What is CME's intrinsic value based on DCF?

Answer: earnings-based $193.55, FCF-based $189.44

Is CME overvalued or undervalued?

Answer: CME is currently overvalued based on DCF and GF Value™ consensus.

How reliable is the DCF model for CME?

Answer: The DCF model's reliability is limited due to a predictability rank of 2/5.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Keysight Technologies, Inc. (NYSE: KEYS) today announced that it completed the acquisition of VPIphotonics on June 9, 2026, adding system-level simulation to its photonic design automation portfolio and enabling optical and electrical engineers to advance designs from component to complete link within a single environment.

Demand for silicon photonics and co-packaged optics continue to grow across data center and AI infrastructure markets. As complexity rises and timelines tighten, engineering teams need simulation that carries a design across every domain without the manual handoffs that slow development and introduce error.

Keysight's photonic design automation portfolio now reaches from device physics to full system behavior. RSoft handles device-level simulation for waveguides, gratings, modulators, and laser sources. Photonic Designer delivers comprehensive circuit-level design and verification for photonic integrated circuits. The acquisition of VPIphotonics now strengthens Keysight's circuit-level design capabilities and extends its photonic design automation portfolio to the system level with VPIphotonics Design Suite. This will enable Keysight to deepen and significantly enhance the design workflow by leveraging industry-leading solutions that the two companies have been shipping for years.

One example of this integrated workflow is VPI Optical Link in Keysight ADS, which enables simulation of the full transceiver path in a single analysis, from electrical to optical and back to electrical (E-O-E). Engineers can then predict how the whole link will perform, including bit error rate, without moving a design between separate electrical and optical tools. Because the workflow connects to Keysight's high-speed digital tools and test instruments, simulation aligns with bench measurements. As a result, issues surface earlier and teams require fewer prototype iterations.

Dr. André Richter, General Manager, VPIphotonics, said: “We have been supporting our customers with value-adding photonic design tools for high-demand applications for decades. Joining Keysight means we can engineer powerful, more complete workflow solutions to serve our customers better.”

Nilesh Kamdar, General Manager, Keysight EDA, said: “Photonics design complexity continues to increase for our customers, especially for those working at speeds greater than 1 THz. Having a complete suite of tools that address these challenges from device to system is crucial. We’re excited to welcome the VPIphotonics team to Keysight and help us address the critical design challenges our joint customers face.”

Terms of the transaction have not been disclosed.

Resources

Web Page: Photonic Design Automation SoftwareWeb Page: VPIphotonicsAbout Keysight Technologies

At Keysight (NYSE: KEYS), we inspire and empower innovators to bring world-changing technologies to life. As an S&P 500 company, we’re delivering market-leading design, emulation, and test solutions to help engineers develop and deploy faster, with less risk, throughout the entire product life cycle. We’re a global innovation partner enabling customers in communications, industrial automation, aerospace and defense, automotive, semiconductor, and general electronics markets to accelerate innovation to connect and secure the world. Learn more at Keysight Newsroom and www.keysight.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260616519087/en/

As frontier AI models compress the entire attack lifecycle, Check Point and Illumio combine perimeter defense with breach containment so organizations can stop attacks at the edge, and contain them if they get through

, /PRNewswire/ -- Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a pioneer and global leader of cyber security solutions, and Illumio Inc., the breach containment company, today announced an expanded strategic partnership to help organizations defend against a new category of threat: frontier AI models capable of autonomously executing full-scale attacks at machine speed.

"Security teams are being asked to defend environments that are moving faster and that are more complex — against attackers who are using AI to do in minutes what used to take weeks," said Paul Barbosa, VP of Cloud & SASE at Check Point. "Expanding our partnership both in terms of joint product development and go-to-market with Illumio gives our customers something attackers don't want them to have: a coordinated defense that works on both sides of the perimeter. Check Point prevents threats from getting in. Illumio ensures they can't run free if they do. Together, we are working to close the gap that every attacker is looking to exploit."

Frontier AI models are changing the nature of cyber attacks. Adversaries can now compress the entire attack lifecycle — discovery, exploitation, and lateral movement — into a single, automated sequence with little or no human involvement. The window between initial access and catastrophic breach is collapsing. For security teams already stretched thin, the critical question is no longer, "can we stop the attack at the door?" It's "if something gets in, can we find it and stop it from spreading before the damage is done?"

This expanded partnership is built to answer both questions. Check Point delivers the industry's best security for the perimeter, data center, and networks — with the best real-time threat prevention against unknown attacks and the most comprehensive Zero Trust security available. Illumio addresses what happens inside the network: visibility into how workloads communicate, exposure of attack paths, and microsegmentation controls that protect critical assets and contain breaches before they cascade into disasters. Together, the two companies deliver protection and resilience as a unified capability. Customers can now procure Illumio directly through Check Point, simplifying vendor consolidation and accelerating deployment.

Building on the 2025 integration with Illumio Insights, which helped security teams connect Check Point threat intelligence with workload visibility to detect lateral movement risk, the expanded partnership now adds deep integration with Illumio Segmentation. Security teams can align Check Point firewall policy with Illumio's workload model across hybrid and multi-cloud environments, reducing unnecessary connectivity and making it significantly harder for attackers to move undetected through the network once inside.

"AI is compressing the time between intrusion and impact, fundamentally changing the math for defenders," said Andrew Rubin, CEO and founder of Illumio. "Cyber security now has two jobs: prevent what you can, and for everything else, find it fast and stop it from spreading. That's exactly why Illumio and Check Point are working together—to help organizations change that math and contain attacks before they become disasters."

The result is a more complete security architecture for the AI era. Check Point's prevention-first enforcement stops threats at key network boundaries. Illumio Insights surfaces suspicious movement and attack paths across hybrid environments. And Illumio Segmentation, now more tightly aligned with Check Point firewall policy, limits how far any threat can travel once inside. For security teams managing more systems, more connectivity, and more change than ever before, this combination means faster detection, smarter decisions, and incidents contained before they become disasters.

"IDC forecasts microsegmentation to grow at 23.5% CAGR as organizations shift from evaluation to scaled deployment, with 96% of buyers experiencing a noticeable improvement in security posture, cyber resiliency, and ransomware preparedness. However, customers today are often overburdened with disparate tools and products, and IDC research shows that 98.3% of microsegmentation buyers prefer their solution to have tight integration with SASE, firewall, or other zero trust technologies," said Pete Finalle, Research Manager at IDC. "This partnership directly addresses these concerns, as microsegmentation and the broader network security stack are integrated as a coherent platform that simplifies limiting lateral movement and enforcing zero trust at scale."

The expanded integration is available now for joint Check Point and Illumio customers. Additional details, including technical integration guidance, are available in the Check Point and Illumio white paper.

Follow Check Point on LinkedIn, X, Facebook, YouTube and our Corporate Blog

About Check Point Software Technologies Ltd.
Check Point Software Technologies Ltd. (www.checkpoint.com) is a global cyber security leader protecting more than 100,000 organizations worldwide. Its mission is to secure enterprises' AI transformation. With a prevention-first approach and an open ecosystem architecture, Check Point helps organizations block advanced threats, prioritize exposures, and automate security operations across complex digital environments. The unified architecture simplifies protection across hybrid networks, multi-cloud environments, digital workspaces, and AI systems. Structured around four strategic pillars, Hybrid Mesh Network Security, Workspace Security, Exposure Management, and AI Security, Check Point delivers consistent protection and visibility across multivendor environments, enabling organizations to reduce risk, improve efficiency, and accelerate innovation without increasing complexity.

Legal Notice Regarding Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements generally relate to future events or our future financial or operating performance. Forward-looking statements in this press release include, but are not limited to, statements related to our expectations regarding our products and solutions, our expectations regarding future growth, the expansion of Check Point's industry leadership, the enhancement of shareholder value and the delivery of an industry-leading cyber security platform to customers worldwide. Our expectations and beliefs regarding these matters may not materialize, and actual results or events in the future are subject to risks and uncertainties that could cause actual results or events to differ materially from those projected. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in our filings with the Securities and Exchange Commission, including our Annual Report on Form 20-F filed with the Securities and Exchange Commission on March 31, 2026. The forward-looking statements in this press release are based on information available to Check Point as of the date hereof, and Check Point disclaims any obligation to update any forward-looking statements, except as required by law.

About Illumio
Illumio is the leader in ransomware and breach containment, redefining how organizations contain cyberattacks and enable operational resilience. Powered by an AI security graph, our breach containment platform identifies and contains threats across hybrid multi-cloud environments – stopping the spread of attacks before they become disasters.

Recognized as a Leader in the Forrester Wave™ for Microsegmentation, Illumio enables Zero Trust, strengthening cyber resilience for the infrastructure, systems, and organizations that keep the world running.

View original content to download multimedia:https://www.prnewswire.com/news-releases/check-point-and-illumio-expand-partnership-to-deliver-protection-and-resilience-against-frontier-ai-powered-attacks-302801966.html

SOURCE Check Point Software Technologies

Forget about the Permian Basin, Guyana, or other oil-rich regions that integrated oil and gas companies have been actively exploring in recent years. Oil and gas giant ConocoPhillips (NYSE: COP) is setting its sights north, far north, to Alaska's North Slope.

While Alaska has been a major oil exploration spot for decades, ConocoPhillips is not pouncing on some run-of-the-mill opportunity. Instead, the company has made this multibillion-dollar project a key component of its cash flow growth strategy.

If successful, this project, known as Willow, could produce billions in incremental cash flow by 2029. Coupled with other efforts, this dramatic surge in profitability could bode well for ConocoPhillips, one of the most widely followed oil stocks.

Image source: Getty Images.

ConocoPhillips and its Willow gambit Expected to cost up to $9 billion, ConocoPhillips' Willow project is the largest Alaskan North Slope energy exploration project in more than 20 years. While the price tag may seem hefty, the potential upside in crude oil production could be substantial. Company forecasts call for peak production of 180,000 barrels per day, with the site ultimately producing over 600 million barrels of recoverable oil.

Today's Change

(

-0.93

%) $

-1.04

Current Price

$

111.22

Although not expected to come online until early 2029, management expects it to have an immediate impact on profitability. Since last year, the company has touted it as the sort of grand finale of its efforts to increase annual cash flow between 2025 and the decade's end.

As discussed in communications to investors, ConocoPhillips remains "well positioned to deliver an expected $7 billion in incremental free cash flow by 2029, including $1 billion each year from 2026 through 2028."

In other words, the company expects to wring out $3 billion in additional cash flow through standard cost-reduction measures, with the remaining $4 billion covered by cash flows from the Willow project.

Does this put shares in the buy zone? Considering ConocoPhillips reported operating cash flow of $19.8 billion in 2025, an incremental $7 billion within three years is quite an improvement. Not only would this increased cash flow likely lead to further dividend growth, but it would also likely continue or even expand the company's share repurchase program.

Assuming much of this cash flow also hits the bottom line, it'll likely serve as an upward driver for ConocoPhillips shares. Trading for around 11 times forward earnings, a slight discount to peers such as ExxonMobil, one can argue that investors have yet to even partially factor in the potential upside from the Willow project.

There may be a good reason for this. ConocoPhillips' forecasts hinge heavily on crude oil staying above $70 per barrel. Oil markets can be unpredictable. It's unclear how factors like geopolitics and global economic health impact energy prices, positively or negatively, four years out.

Nevertheless, while only time will tell whether ConocoPhillips' Willow gambit pays off, consider it a strong potential catalyst, atop a myriad of strengths. Besides a reasonable valuation, ConocoPhillips is also one of the top dividend oil stocks, with a 2.9% forward dividend, and over the past five years has experienced double-digit annual dividend growth.

Considering all factors, shares appear to be in the buy zone at current prices.